GeoVax Labs EFFECT Filing Accepted
Ticker: GOVX · Form: EFFECT · Filed: Apr 20, 2026 · CIK: 0000832489
Sentiment: neutral
Topics: filing-effectiveness, registration-statement, pharmaceuticals
TL;DR
GeoVax Labs EFFECT filing effective 4/17/26, accepted 4/20/26.
AI Summary
GeoVax Labs, Inc. filed an EFFECT form on April 20, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-001237, was accepted at 00:15:21. The effectiveness date is listed as April 17, 2026.
Why It Matters
This filing signifies that a registration statement for GeoVax Labs, Inc. has become effective, which is a crucial step for certain securities offerings or corporate actions.
Risk Assessment
Risk Level: low — An EFFECT filing itself is a procedural notification and does not inherently carry financial risk.
Key Numbers
- 2026-04-17 — Effectiveness Date (The date the registration statement became effective.)
- 2026-04-20 — Acceptance Date (The date the SEC accepted the filing.)
Key Players & Entities
- GeoVax Labs, Inc. (company) — Filer
- 9999999995-26-001237 (dollar_amount) — SEC Accession Number
- 2026-04-20 (dollar_amount) — Acceptance Date
- 2026-04-17 (dollar_amount) — Effectiveness Date
FAQ
What is the SEC Accession Number for this filing?
The SEC Accession Number is 9999999995-26-001237.
What is the effectiveness date indicated in the filing?
The effectiveness date is April 17, 2026.
When was this EFFECT filing accepted by the SEC?
The filing was accepted on April 20, 2026, at 00:15:21.
What is the CIK number for GeoVax Labs, Inc.?
The CIK number for GeoVax Labs, Inc. is 0000832489.
What is the primary business of GeoVax Labs, Inc. according to the filing?
GeoVax Labs, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 20, 2026 regarding GeoVax Labs, Inc. (GOVX).